Back

Explore every episode of the podcast Voices of Wisdom: A Podcast for Thyroid Clinicians

Dive into the complete episode list for Voices of Wisdom: A Podcast for Thyroid Clinicians. Each episode is cataloged with detailed descriptions, making it easy to find and explore specific topics. Keep track of all episodes from your favorite podcast and never miss a moment of insightful content.

Rows per page:

1–28 of 28

TitlePub. DateDuration
What’s New in the ATA Guidelines for Thyroid Nodules? (Part 2)15 sept. 202600:22:29

Part 2 turns from the proposed guideline framework to its potential use in practice. Dr. Mandel explains how clearer follow-up intervals may help de-escalate surveillance for benign nodules. She also identifies the clinicians most likely to use the planned app, particularly those who interpret ultrasound and make decisions about FNA.

The conversation examines why thyroid ultrasound remains subjective, even as imaging technology improves. Dr. Mandel discusses commonly overcalled features, variation among readers and the importance of evaluating nodules through real-time imaging rather than relying only on selected static images. These limitations help frame both the promise and the challenge of using AI in thyroid ultrasound.

Dr. Mandel sees an especially valuable role for AI in medical education, where it could help less experienced readers strengthen their interpretation skills. She also imagines future clinical tools that integrate patient factors, imaging and cytology into a more complete risk assessment. The episode closes on a personal note as she reflects on mentorship, curiosity, patient relationships and the importance of building a meaningful life beyond one’s career.

What’s New in the ATA Guidelines for Thyroid Nodules? (Part 1)18 août 202600:26:24

Dr. Susan Mandel traces her path into thyroid care back to mentorship, curiosity and an unexpected research opportunity. She explains how a practical need to perform ultrasound-guided biopsies more efficiently helped launch her work with thyroid nodules. What began as a way to obtain better samples from cystic or deep nodules soon revealed ultrasound’s much broader diagnostic potential.

The conversation follows ultrasound’s evolution from a procedural aid to an essential tool for estimating malignancy risk. Dr. Mandel discusses improvements in probes and image processing, along with an enduring challenge: clinicians must learn how different machines and settings influence what they see. She also connects this progress to the Bethesda System and sonographic risk-stratification frameworks that helped shift practice away from biopsying every nodule above a certain size.

Looking ahead, Dr. Mandel previews how the forthcoming ATA thyroid nodule guidelines may refine classification and support more patient-centered FNA decisions. She describes a planned app that would guide clinicians through nodule features, assign a sonographic category and provide supporting images. The discussion also explores how clinical history, comorbidities, nodule location and patient preference may help determine when biopsy or surveillance is appropriate.

Follicular Thyroid Lesions: What Pathology Reveals with Dr. Baloch21 juil. 202600:35:10

Dr. Dana Hartl welcomes thyroid pathologist Dr. Zubair Baloch for a practical discussion of follicular-patterned thyroid lesions and why they remain challenging to classify. Dr. Baloch explains that “follicular” can describe both a cell of origin and a growth pattern, then walks listeners through the overlap among benign nodules, adenomas and carcinomas. He also clarifies why cytology can identify a follicular neoplasm but cannot reliably determine whether capsular or vascular invasion is present.

The conversation explores how invasion affects diagnosis and prognosis. Dr. Baloch distinguishes capsular invasion from angioinvasion, explains why adequate tumor sampling is essential and discusses how the extent of vascular invasion can change clinical risk. He emphasizes that pathology terminology must be precise and descriptive, particularly because patients may see their reports before speaking with their clinicians.

Dr. Hartl and Dr. Baloch also examine how molecular findings have reshaped thyroid tumor classification. They discuss the differing behavior of RAS-driven and BRAF-driven tumors, the separate classification of oncocytic carcinoma and the reasoning behind removing the word “carcinoma” from NIFTP. Dr. Baloch closes with a valuable reminder that pathology diagnoses should be grounded in everyday clinical practice, communicated clearly and written with patient management in mind.

Small Thyroid Nodules: When to Watch, Biopsy or Treat with Dr. Alexander23 juin 202600:28:33

In this episode of Voices of Wisdom, Dr. Erik Alexander joins Dr. Dana Hartl for a practical conversation about managing small thyroid nodules in an era of widespread ultrasound use and increasing incidental findings. The discussion centers on how clinicians can weigh nodule size, ultrasound features, cytology, patient age, comorbidities and personal risk tolerance when deciding whether to pursue FNA, active surveillance or treatment.

One of the strongest insights is the importance of context. Dr. Alexander emphasizes that many thyroid nodules, and even some low-risk thyroid cancers, may never become clinically significant. Rather than defaulting to intervention, he frames care as a stepwise process with multiple points for reassessment, conversation and shared decision-making.

The episode also explores the emotional weight of terminology, especially the word “cancer,” and how clinicians can help patients understand risk without minimizing their concerns. Dr. Alexander also looks ahead to the role of AI in thyroid ultrasound and cytology, while reinforcing that technology should support, not replace, clinician judgment and patient-centered discussion.

2025 Updated ATA Guidelines with Dr. Sosa: What Has Changed? (Part 2)19 mai 202600:33:53

What happens when the evidence is incomplete, the terminology changes and the old follow-up habits no longer fit? In Part 2 of this thoughtful conversation, Dr. Julie Ann Sosa takes listeners into the gray zones of the 2025 ATA guidelines, from pathology and posterior tumors to surveillance limits and the future of decision support. It is a engaging conversation about where thyroid cancer care is becoming more precise and where the field still has hard questions to answer.

2025 Updated ATA Guidelines with Dr. Sosa: What Has Changed?21 avr. 202600:23:29

In Part 1 of their discussion, Dr. Dana Hartl and Dr. Julie Ann Sosa unpack the years-long process behind the update and the biggest shifts already changing how clinicians think about surgery, surveillance and personalized care. It is an inside look at guideline-making that feels as revealing as the recommendations themselves.

Medullary Thyroid Carcinoma (Part 2): A Surgeon’s Perspective with Dr. Lorenz17 mars 202600:22:12

In part 2, we examine evolving surgical paradigms in medullary thyroid carcinoma, including staged surgery, de-escalation strategies and the use of frozen section findings to guide extent of resection. Dr. Lorenz also discusses follow-up after limited surgery and when neoadjuvant RET inhibitor therapy may make previously unresectable disease operable.

Medullary Thyroid Carcinoma: A Surgeon’s Perspective with Dr. Lorenz17 févr. 202600:27:02

This two-part episode focuses on surgical decision making in medullary thyroid carcinoma, from patient selection to preoperative workup. Dr. Kerstin Lorenz explains how calcitonin levels, ultrasound findings and genetic considerations shape staging, imaging choices and the initial extent of surgery, with an emphasis on avoiding overtreatment while preserving curative intent.

Beyond Bethesda (Part 2): FNA, Molecular Tests & AI in Pathology with Dr. Baloch20 janv. 202600:20:27

In this second part of their discussion, Dr. Dana Hartl sits down with Dr. Zubair Baloch for a practical conversation on what actually makes thyroid FNA cytology reliable. The episode challenges common assumptions about “adequate” sampling and why that single step quietly shapes every diagnosis that follows. They also tease how molecular testing and AI can help, and when they can mislead, if the fundamentals are not right.

Beyond Bethesda: Cytopathologic Diagnosis of Thyroid Tumors16 déc. 202500:20:31

Thyroid cytology can be clear at the extremes, but uncertainty dominates the middle ground. In this episode, Dr. Zubair Baloch explores why indeterminate nodules challenge clinicians and how context, judgment, and collaboration shape better decisions. It’s a thoughtful look at what lies beyond Bethesda—and why everything matters.

Personalizing Thyroid Hormone Therapy in Cancer Care18 nov. 202500:31:38

In this episode, Dr. Dana Hartl speaks with Dr. J.P. Brito from the Mayo Clinic about the art and science of thyroid hormone replacement therapy. Together, they explore balancing TSH suppression, managing persistent symptoms, and understanding when “normal” lab results don’t tell the full story. Tune in for expert insights that challenge assumptions and highlight the power of individualized care.

Intraoperative Neuromonitoring: What Clinicians Should Know21 oct. 202500:42:00

What if surgeons could see nerve function in real time—and prevent injury before it happens? In this episode, Dr. Catherine Sinclair reveals how intraoperative neuromonitoring is reshaping thyroid surgery worldwide. From technical nuances to global access challenges, listeners gain a rare insider’s look at how innovation is transforming surgical precision.

Expert Tips & Tricks for Thyroid Cancer Ultrasound16 sept. 202500:32:34

Dr. Lisa Orloff shares practical, experience-driven tips for optimizing thyroid cancer ultrasound—from honing diagnostic skills and scanning overlooked areas to guiding surgery and follow-up care. Her expert insights help clinicians improve accuracy, integrate ultrasound into patient management, and adopt interactive techniques for better outcomes.

Understanding Financial Toxicity in Thyroid Cancer19 août 202500:26:12

What happens when a cancer diagnosis impacts more than just your health? In this episode, Dr. Carrie Cunningham joins us to explore financial toxicity in thyroid cancer—what it is, why it matters, and how we can measure it. She also shares surprising insights about global policies and the promising role of AI in reducing patient burden.

Unresectable vs. Resectable Thyroid Cancer (Pt. 2)15 juil. 202500:27:45

What changes when thyroid tumors once considered inoperable become surgical candidates? Dr. Mark Zafereo joins Dr. Dana Hartl to explore how neoadjuvant therapy reshapes surgical timing, decision-making, and long-term care for patients with aggressive thyroid cancer. This discussion uncovers clinical judgment calls, imaging insights & evolving surgical strategies you won't want to miss.

Unresectable vs. Resectable Thyroid Cancer (Pt. 1)17 juin 202500:27:13

What makes a thyroid tumor truly unresectable? In this episode, Dr. Dana Hartl speaks with Dr. Mark Zafereo about how molecular testing and targeted neoadjuvant therapies are redefining surgical eligibility for patients with anaplastic thyroid cancer. Listen in as they explore the evolving role of BRAF/MEK inhibitors, imaging strategies, and real-world decision-making in complex cases.

Around the World in 3 Clinical Case Scenarios (Pt. 2)20 mai 202500:24:31

In the continuation of this episode of Voices of Wisdom, Dr. Dana Hartl hosts Drs. Fabian Pitoia and Iwao Sugitani for a global discussion on thyroid cancer management. Together, they examine real-world cases and explore differing international approaches to active surveillance, surgery and treatment strategies. Gain insight into how cultural values and evolving guidelines shape care decisions around the world.

Around the World in 3 Clinical Case Scenarios (Pt. 1)15 avr. 202500:20:52

In this thought-provoking episode of Voices of Wisdom, Dr. Dana Hartl hosts Drs. Fabian Pitoia and Iwao Sugitani for a global discussion on thyroid cancer management. Together, they examine real-world cases and explore differing international approaches to active surveillance, surgery and treatment strategies. Gain insight into how cultural values and evolving guidelines shape care decisions around the world.

Radioactive Iodine: Unraveling the Mystery (Part 2)18 mars 202500:25:40

In Part 2 of this episode of Voices of Wisdom, Dr. Dana Hartl continues her conversation with Dr. David Pattison, diving deeper into radioactive iodine therapy for thyroid cancer. They discuss the biological mechanisms of I-131, key differences from external beam radiation, and evolving strategies for personalized treatment. Dr. Pattison also explores future advancements, including re-differentiation therapy and the role of nuclear medicine in optimizing patient care.

Feel free to send your questions or suggestions about future episodes to voicesofwisdompodcast@gmail.com.

To subscribe to receive info about upcoming TIROxMDS webinars, click here: tiro.expert/subscribe

Radioactive Iodine: Unraveling the Mystery18 févr. 202500:28:21

Dr. Dana Hartl speaks with Dr. David Pattison about radioactive iodine therapy for thyroid cancer, breaking down different isotopes, their applications, and the importance of theranostics. They discuss how pre-therapy imaging can help personalize treatment and avoid ineffective therapies. Dr. Pattison also explains the role of dosimetry and how institutions like Royal Brisbane and Women’s Hospital optimize care for thyroid cancer patients.

Feel free to send your questions or suggestions about future episodes to voicesofwisdompodcast@gmail.com.

To subscribe to receive info about upcoming TIROxMDS webinars, click here: tiro.expert/subscribe

Démystifier le lien entre la radiation & le cancer de la thyroïde21 janv. 202500:23:05

Pour nos francophones, notre animatrice et notre invité (tous deux francophones) ont généreusement enregistré leur interview en anglais et en français.

Le Dr Dana Hartl interviewe le Professeur Martin Schlumberger pour démystifier les idées reçues sur le cancer de la thyroïde et ses liens avec les radiations. Ils abordent des facteurs clés tels que la dose de radiation, l'âge lors de l'exposition et les mesures proactives qui réduisent les risques, en s'appuyant sur les enseignements tirés des incidents de Tchernobyl et de Fukushima. L'épisode souligne l'importance de soins fondés sur des preuves et d'une communication efficace avec les patients concernant les risques liés aux radiations.

N'hésitez pas à envoyer vos questions ou suggestions pour de futurs épisodes à voicesofwisdompodcast@gmail.com.

Pour vous abonner et recevoir des informations sur les prochains webinaires TIROxMDS, cliquez ici : tiro.expert/subscribe

Debunking the Connection Between Radiation & Thyroid Cancer21 janv. 202500:19:35

For French speakers, our host and guest (both fluent in French) generously recorded their interview in English and French.

Dr. Dana Hartl interviews Professor Martin Schlumberger to debunk myths about thyroid cancer and its links to radiation. They discuss key factors like radiation dose, age of exposure, and proactive measures that reduce risks, using insights from Chernobyl and Fukushima. The episode underscores the importance of evidence-based care and effective patient communication about radiation risks.

Feel free to send your questions or suggestions about future episodes to voicesofwisdompodcast@gmail.com.

To subscribe to receive info about upcoming TIROxMDS webinars, click here: tiro.expert/subscribe

Thyroid Cancer & Pregnancy17 déc. 202400:25:12

In this episode of Voices of Wisdom, Dr. Janice Pasieka hosts Dr. Angela Leung to discuss managing thyroid cancer during pregnancy. They delve into the complexities and reassuring aspects of monitoring thyroid nodules in pregnant women, emphasizing a multidisciplinary approach for optimal care. Dr. Leung shares valuable insights on the timing of surgical interventions and the special considerations for radioactive iodine treatment post-pregnancy. The episode highlights the importance of tailored patient care and long-term planning. Tune in to learn about the nuanced strategies for handling this challenging clinical scenario.

Feel free to send your questions or suggestions about future episodes to voicesofwisdompodcast@gmail.com.

To subscribe to receive info about upcoming TIROxMDS webinars, click here: tiro.expert/subscribe

Molecular Diagnostics19 nov. 202400:20:19

In the latest episode of TIRO’s Voices of Wisdom podcast, Dr. Janice Pasieka hosts Dr. Erik Alexander, a leading endocrinologist from Brigham and Women's Hospital in Boston, to discuss the evolving role of molecular diagnostics in thyroid cancer management. They delve into the types of molecular testing available, particularly Afirma and ThyroSeq version 3, highlighting their diagnostic and prognostic applications for intermediate thyroid nodules. Dr. Alexander shares insights on when to utilize these tests, their impact on clinical decisions, and the significance of understanding molecular signatures in advanced disease. The episode wraps up with Dr. Alexander revealing a hidden gem in Boston offering a unique historical experience for visitors.

Feel free to send your questions or suggestions about future episodes to voicesofwisdompodcast@gmail.com.

To subscribe to receive info about upcoming TIROxMDS webinars, click here: tiro.expert/subscribe

Surgeons vs. the Unexpected - Part 215 oct. 202400:20:22

In the second part of this special episode of Voices of Wisdom, Dr. Janice Pasieka, Dr. Ashok Shaha and Dr. Mark Urken continue their discussion on the unexpected challenges surgeons face during thyroid cancer surgeries. They delve into critical decisions when encountering extensive nodal disease and the intricacies of preserving the recurrent laryngeal nerve. The conversation highlights the importance of preoperative evaluations and the emotional and technical complexities surgeons navigate in the operating room. Each expert shares their unique approaches and invaluable insights, offering listeners a deep dive into the art of thyroid surgery. Tune in for a compelling conclusion that combines medical expertise with personal anecdotes from these renowned surgeons.

Feel free to send your questions or suggestions about future episodes to voicesofwisdompodcast@gmail.com.

To subscribe to receive info about upcoming TIROxMDS webinars, click here: tiro.expert/subscribe

Surgeons vs. the Unexpected - Part 117 sept. 202400:25:29

In this special two-part episode of Voices of Wisdom, Dr. Janice Pasieka hosts a fascinating discussion with renowned thyroid cancer surgeons, Dr. Ashok Shaha and Dr. Mark Urken. They delve into the unexpected challenges surgeons face during thyroid cancer surgeries, particularly when encountering unexpected tracheal invasion. The experts share their preoperative strategies and intraoperative decision-making processes, offering invaluable insights for both seasoned and aspiring clinicians. The episode is filled with practical advice and thought-provoking analogies that highlight the complexities of thyroid cancer surgeries. Tune in to part one to gain unique perspectives from these surgical giants and stay tuned for part two, where the conversation continues.

Feel free to send your questions or suggestions about future episodes to voicesofwisdompodcast@gmail.com.

To subscribe to receive info about upcoming TIROxMDS webinars, click here: tiro.expert/subscribe 

Active Surveillance20 août 202400:20:10

In this episode of Voices of Wisdom, host Janice Pasieka and expert guest Eyal Robenshtok dive into the revolutionary approach of active surveillance in thyroid cancer treatment. They explore how this method challenges traditional surgery-first strategies, offering valuable insights for clinicians. Discover the criteria for selecting patients for active surveillance and the nuanced considerations that come into play. The discussion also touches on the evolving landscape of patient care and the significance of a cohesive medical team. Tune in to learn from top-tier international expertise and get a glimpse of Robenshtok's favorite travel spot.

Feel free to send your questions or suggestions about future episodes to voicesofwisdompodcast@gmail.com.

To subscribe to receive info about upcoming TIROxMDS webinars, click here: tiro.expert/subscribe 

Rising Thyroglobulin Levels16 juil. 202400:26:42

Welcome to the inaugural episode of TIRO's Voices of Wisdom podcast, hosted by Dr. Janice Pasieka, a surgical endocrinologist from Calgary. This series promises to be an essential resource for clinicians managing thyroid cancer, providing practical advice through discussions with international experts.

In this episode, Dr. Michael Tuttle of Memorial Sloan Kettering shares his insights on managing rising thyroglobulin levels in post-treatment follow-ups. The conversation covers detailed protocols for follow-up care, the importance of specialist consultations, and a strategic approach to the challenges of persistent disease markers. This podcast aims to complement TIRO's existing educational materials, enhancing the clinicians' toolkit with actionable knowledge for complex clinical scenarios.

Feel free to send your questions or suggestions about future episodes to voicesofwisdompodcast@gmail.com.

To subscribe to receive info about upcoming TIROxMDS webinars, click here: tiro.expert/subscribe 

© My Podcast Data · Independent project · Data from Apple & Spotify